Highlights • Tuberculosis (TB) is the second leading cause of mortality from an infectious disease worldwide. • Prevalence of MTB was 9.7 % (95 % CI: 9.2–10.2 %). • Rifampicin resistant-MTB from the MTB positive patients was 8.7 % (95 % CI: 7.32–10.09 %). • Age groups of 18–29 years were associated with higher RR-MTB.
All Keywords
【저자키워드】 Ethiopia, MDR-TB, Tigray, Rifampicin resistance, Xpert MTB/RIF assay,
【저자키워드】 Ethiopia, MDR-TB, Tigray, Rifampicin resistance, Xpert MTB/RIF assay,